ClinicalTrials.Veeva

Menu

Treatment of Periodontal Intra-bony Defects With a Volume Stable Collagen Matrix or Deproteinized Bovine Bone Mineral With 10% Collagen

U

University of Bern

Status

Enrolling

Conditions

Periodontal Diseases

Treatments

Device: Infrabony defects will be filled with a volume-stable collagen matrix (VCMX)
Device: Infrabony defects will be filled treated with a deproteinized bovine bone mineral with 10% collagen

Study type

Interventional

Funder types

Other

Identifiers

NCT06676826
2024-D0026

Details and patient eligibility

About

To compare the healing of intrabony periodontal defects treated with either open flap debridement and a volume-stable collagen matrix (VCMX) or a deproteinized bovine bone mineral with 10% collagen. The results will shed light on the clinical potential of VCMX in regenerative periodontal surgery and help to develop new treatment strategies.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Patients with localized or generalized periodontitis Stage III and Stage IV, Grade A-B-C
  • Males and females
  • Age at least 18 years and older
  • Presence of interdental intra-bony defects (I, II and III walls) in either the maxilla or the mandible with a PD ≥ 6 mm
  • Defects with an intra-bony component > 3 mm for both groups
  • Intra-bony defect located only at one aspect (mesial or distal)
  • Presence of at least 2 mm of keratinized soft tissue. Exclusion Criteria
  • Patients with systemic disease that could interfere with periodontal wound healing
  • Prolonged antibiotic treatment or anti-inflammatory treatment within 4 weeks prior to surgery
  • Pregnant or lactating
  • Smokers with > 10 cig./day
  • Patients with FMPS and FMBS > 25 % after completion of non-surgical periodontal therapy
  • Multi-rooted teeth with furcation involvement
  • Third molars
  • Teeth with circumferential defects
  • Interdental craters
  • Written Informed Consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups

Test Group (VCMX)
Experimental group
Description:
The periodontal infrabony defect will be opened by a papilla preservation flap, the root surface will be thoroughly cleaned with hand instruments and ultrasonic scalers, then the bony defect will be filled with a volume-stable collagen matrix (VCMX) only.
Treatment:
Device: Infrabony defects will be filled with a volume-stable collagen matrix (VCMX)
Control Group (Deproteinized bovine bone mineral)
Active Comparator group
Description:
The periodontal infrabony defect will be opened by a flap, the root surface will be thoroughly cleaned with hand instruments and ultrasonic scalers, then the bony defect will be filled with deproteinized bovine bone mineral with 10% collagen.
Treatment:
Device: Infrabony defects will be filled treated with a deproteinized bovine bone mineral with 10% collagen

Trial contacts and locations

1

Loading...

Central trial contact

Alexandra Stähli, MD; Andrea Roccuzzo, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems